Select Historical Income Statement

SEM Stock

USD 21.34 0.50 2.40%

Historical analysis of Select Medical income statement accounts such as Other Operating Expenses of 3.8 B, Operating Income of 378.2 M, EBIT of 391 M or Ebitda of 526.3 M can show how well Select Medical Holdings performed in making a profits. Evaluating Select Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Select Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Select Medical Holdings latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Select Medical Holdings is a good buy for the upcoming year.

Net Income Gross Profit

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

About Select Income Statement Analysis

Select Medical Holdings Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Select Medical shareholders. The income statement also shows Select investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Select Medical Income Statement Chart

At this time, Select Medical's Selling And Marketing Expenses is very stable compared to the past year. As of the 28th of November 2024, Non Recurring is likely to grow to about 96 M, while Interest Expense is likely to drop about 152.3 M.

Total Revenue Gross Profit Other Operating Expenses Operating Income

Total Revenue

Total revenue comprises all receipts Select Medical Holdings generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Select Medical Holdings minus its cost of goods sold. It is profit before Select Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Select Medical Holdings. It is also known as Select Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Operating Income

Operating Income is the amount of profit realized from Select Medical Holdings operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Select Medical Holdings is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Most accounts from Select Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Select Medical Holdings current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Select Medical Holdings. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.

	2021	2022	2023	2024 (projected)
Interest Expense	136.0M	169.1M	198.6M	152.3M
Depreciation And Amortization	202.6M	205.8M	208.7M	135.3M

Interest Expense Depreciation And Amortization

Select Medical income statement Correlations

	Depreciation And Amortization	Interest Expense	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Selling General Administrative	Selling And Marketing Expenses	Minority Interest	Net Income From Continuing Ops	Non Recurring	Non Operating Income Net Other	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Extraordinary Items
Depreciation And Amortization		0.91	0.93	0.92	0.93	0.76	0.75	0.9	0.92	0.79	0.6	-0.78	0.65	0.24	0.52	0.4	0.28	0.64	0.54	0.4	0.08	0.38	-0.16	0.8	-0.09
Interest Expense	0.91		0.79	0.78	0.81	0.5	0.58	0.75	0.79	0.92	0.29	-0.8	0.36	-0.04	0.56	0.31	0.01	0.38	0.58	0.29	-0.14	0.42	-0.44	0.72	-0.24
Total Revenue	0.93	0.79		0.96	1.0	0.85	0.83	0.93	1.0	0.71	0.74	-0.68	0.77	0.4	0.52	0.51	0.14	0.7	0.5	0.58	0.2	0.13	-0.04	0.78	-0.16
Gross Profit	0.92	0.78	0.96		0.95	0.92	0.89	0.96	0.95	0.66	0.81	-0.68	0.85	0.4	0.5	0.49	0.28	0.76	0.56	0.51	0.22	0.07	-0.01	0.78	-0.18
Other Operating Expenses	0.93	0.81	1.0	0.95		0.82	0.8	0.91	1.0	0.74	0.71	-0.69	0.74	0.36	0.54	0.49	0.1	0.68	0.49	0.56	0.18	0.15	-0.06	0.79	-0.17
Operating Income	0.76	0.5	0.85	0.92	0.82		0.88	0.89	0.83	0.35	0.96	-0.52	0.96	0.66	0.32	0.52	0.42	0.85	0.48	0.55	0.48	-0.13	0.18	0.72	-0.13
Ebit	0.75	0.58	0.83	0.89	0.8	0.88		0.96	0.82	0.36	0.85	-0.42	0.9	0.54	0.12	0.73	0.31	0.7	0.35	0.58	0.17	-0.02	0.07	0.55	-0.16
Ebitda	0.9	0.75	0.93	0.96	0.91	0.89	0.96		0.92	0.56	0.81	-0.6	0.85	0.45	0.29	0.64	0.32	0.72	0.45	0.54	0.14	0.15	-0.02	0.69	-0.14
Cost Of Revenue	0.92	0.79	1.0	0.95	1.0	0.83	0.82	0.92		0.71	0.73	-0.67	0.76	0.39	0.52	0.5	0.12	0.69	0.48	0.58	0.2	0.14	-0.04	0.78	-0.16
Total Operating Expenses	0.79	0.92	0.71	0.66	0.74	0.35	0.36	0.56	0.71		0.12	-0.78	0.18	-0.22	0.72	0.07	-0.14	0.26	0.53	0.12	-0.18	0.36	-0.45	0.66	-0.22
Income Before Tax	0.6	0.29	0.74	0.81	0.71	0.96	0.85	0.81	0.73	0.12		-0.3	0.98	0.78	0.18	0.54	0.45	0.86	0.3	0.63	0.57	-0.23	0.35	0.57	-0.07
Total Other Income Expense Net	-0.78	-0.8	-0.68	-0.68	-0.69	-0.52	-0.42	-0.6	-0.67	-0.78	-0.3		-0.34	-0.07	-0.53	-0.3	0.08	-0.38	-0.64	-0.08	-0.04	-0.19	0.59	-0.89	0.43
Net Income	0.65	0.36	0.77	0.85	0.74	0.96	0.9	0.85	0.76	0.18	0.98	-0.34		0.67	0.2	0.55	0.47	0.84	0.33	0.58	0.43	-0.2	0.33	0.57	-0.08
Income Tax Expense	0.24	-0.04	0.4	0.4	0.36	0.66	0.54	0.45	0.39	-0.22	0.78	-0.07	0.67		-0.17	0.52	0.24	0.57	-0.02	0.59	0.81	-0.31	0.17	0.37	-0.04
Selling General Administrative	0.52	0.56	0.52	0.5	0.54	0.32	0.12	0.29	0.52	0.72	0.18	-0.53	0.2	-0.17		-0.36	-0.02	0.42	0.46	0.25	0.19	-0.03	-0.05	0.56	-0.2
Selling And Marketing Expenses	0.4	0.31	0.51	0.49	0.49	0.52	0.73	0.64	0.5	0.07	0.54	-0.3	0.55	0.52	-0.36		-0.13	0.31	0.17	0.45	0.02	-0.1	-0.24	0.39	-0.41
Minority Interest	0.28	0.01	0.14	0.28	0.1	0.42	0.31	0.32	0.12	-0.14	0.45	0.08	0.47	0.24	-0.02	-0.13		0.44	0.03	0.01	0.2	0.34	0.59	0.0	0.59
Net Income From Continuing Ops	0.64	0.38	0.7	0.76	0.68	0.85	0.7	0.72	0.69	0.26	0.86	-0.38	0.84	0.57	0.42	0.31	0.44		0.17	0.54	0.54	-0.25	0.24	0.63	-0.16
Non Recurring	0.54	0.58	0.5	0.56	0.49	0.48	0.35	0.45	0.48	0.53	0.3	-0.64	0.33	-0.02	0.46	0.17	0.03	0.17		0.18	-0.01	0.1	-0.18	0.61	-0.35
Non Operating Income Net Other	0.4	0.29	0.58	0.51	0.56	0.55	0.58	0.54	0.58	0.12	0.63	-0.08	0.58	0.59	0.25	0.45	0.01	0.54	0.18		0.49	-0.22	0.17	0.43	-0.3
Tax Provision	0.08	-0.14	0.2	0.22	0.18	0.48	0.17	0.14	0.2	-0.18	0.57	-0.04	0.43	0.81	0.19	0.02	0.2	0.54	-0.01	0.49		-0.46	0.18	0.37	-0.09
Interest Income	0.38	0.42	0.13	0.07	0.15	-0.13	-0.02	0.15	0.14	0.36	-0.23	-0.19	-0.2	-0.31	-0.03	-0.1	0.34	-0.25	0.1	-0.22	-0.46		-0.07	-0.01	0.55
Net Interest Income	-0.16	-0.44	-0.04	-0.01	-0.06	0.18	0.07	-0.02	-0.04	-0.45	0.35	0.59	0.33	0.17	-0.05	-0.24	0.59	0.24	-0.18	0.17	0.18	-0.07		-0.38	0.59
Reconciled Depreciation	0.8	0.72	0.78	0.78	0.79	0.72	0.55	0.69	0.78	0.66	0.57	-0.89	0.57	0.37	0.56	0.39	0.0	0.63	0.61	0.43	0.37	-0.01	-0.38		-0.51
Extraordinary Items	-0.09	-0.24	-0.16	-0.18	-0.17	-0.13	-0.16	-0.14	-0.16	-0.22	-0.07	0.43	-0.08	-0.04	-0.2	-0.41	0.59	-0.16	-0.35	-0.3	-0.09	0.55	0.59	-0.51

Click cells to compare fundamentals

Select Medical Account Relationship Matchups

Select Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	237.6M	205.7M	202.6M	205.8M	208.7M	135.3M
Interest Expense	200.6M	153.0M	136.0M	169.1M	198.6M	152.3M
Total Revenue	5.5B	5.5B	6.2B	6.3B	6.7B	4.2B
Gross Profit	812.9M	821.3M	919.4M	733.4M	932.0M	639.3M
Other Operating Expenses	5.0B	5.0B	5.5B	5.9B	6.1B	3.8B
Operating Income	471.9M	567.7M	713.8M	403.3M	554.9M	378.2M
Ebit	471.9M	477.6M	570.1M	379.5M	554.9M	391.0M
Ebitda	709.4M	683.3M	772.7M	585.3M	763.6M	526.3M
Cost Of Revenue	4.6B	4.7B	5.3B	5.6B	5.7B	3.5B
Total Operating Expenses	341.0M	253.7M	205.6M	330.1M	377.2M	242.1M
Income Before Tax	264.7M	456.5M	629.7M	260.6M	382.4M	236.2M
Total Other Income Expense Net	(207.1M)	(111.2M)	(84.1M)	(142.7M)	(172.5M)	(163.9M)
Net Income	201.0M	259.0M	402.2M	159.0M	243.5M	150.2M
Income Tax Expense	63.7M	111.9M	129.8M	62.6M	82.6M	62.9M
Selling General Administrative	128.5M	138.0M	147.0M	153.0M	170.2M	119.3M
Net Income Applicable To Common Shares	148.4M	259.0M	402.2M	153.4M	176.4M	153.0M
Minority Interest	52.6M	85.6M	97.7M	(39.0M)	(56.2M)	(53.4M)
Net Income From Continuing Ops	201.0M	344.6M	499.9M	198.0M	299.7M	249.3M
Non Operating Income Net Other	(6.6M)	41.8M	46.6M	26.4M	30.4M	31.9M
Tax Provision	63.7M	111.9M	129.8M	62.6M	82.6M	75.6M
Interest Income	176.6M	175.6M	123.6M	5.4M	142.7M	0.0
Net Interest Income	(200.6M)	(153.0M)	(130.6M)	(169.1M)	(198.6M)	(208.6M)
Reconciled Depreciation	212.6M	205.7M	202.6M	205.8M	208.7M	219.5M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Select Medical Holdings is a strong investment it is important to analyze Select Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Select Medical's future performance. For an informed investment choice regarding Select Stock, refer to the following important reports:

How To Invest In Select

Details

Is Select Stock a good investment?

Details

What is Select Medical's Net Worth?

Details

Largest Health Care Providers & Services Companies

View

Largest Health Care Equipment & Services Companies

View

You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Select Medical. If investors know Select will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Select Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.139

Dividend Share

0.5

Earnings Share

2.14

Revenue Per Share

56.158

Quarterly Revenue Growth

0.057

The market value of Select Medical Holdings is measured differently than its book value, which is the value of Select that is recorded on the company's balance sheet. Investors also form their own opinion of Select Medical's value that differs from its market value or its book value, called intrinsic value, which is Select Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Select Medical's market value can be influenced by many factors that don't directly affect Select Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Select Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Select Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Select Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Select Historical Income Statement

About Select Income Statement Analysis

Select Medical Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Operating Income

Select Medical income statement Correlations

Select Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Select Medical income statement Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Other Operating Expenses	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Total Revenue
Cost Of Revenue	+ 1.0	Other Operating Expenses
Net Income	+ 0.98	Income Before Tax
Gross Profit	+ 0.96	Total Revenue
Ebitda	+ 0.96	Gross Profit

Reconciled Depreciation	- 0.89	Total Other Income Expense Net
Total Other Income Expense Net	- 0.8	Interest Expense
Total Other Income Expense Net	- 0.78	Total Operating Expenses
Total Other Income Expense Net	- 0.78	Depreciation And Amortization
Total Other Income Expense Net	- 0.69	Other Operating Expenses
Total Other Income Expense Net	- 0.68	Gross Profit